Ease restrictions on medical psychedelics to aid research, experts say

Psilocybin may be safe for treating depression but research is stymied by government controls

Potential treatments for severe depression, addiction and other mental health disorders are being held up by excessive restrictions on psilocybin, the active ingredient in magic mushrooms, scientists and politicians have said.

Clinical trials suggest that psilocybin may be a safe and effective medicine for patients with certain psychiatric illnesses who do not respond to talking therapies, antidepressants and other drugs. But researchers say their work is being stymied by the government placing the strictest possible controls on the chemical compound.

Continue reading...

from The Guardian https://ift.tt/32ZQQM2